Guardant Health, Inc. (Nasdaq: GH), a leading precision oncology company, today announced the public launch of the Single Namespace Working Group (SNS), a 34-member, cross-industry consortium which ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback